🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Turkey / NCT07164820
Starting soon Not applicable

The Effect of Su Jok Therapy on Pain During Heel LanceProcedure in Newborn

NCT07164820 · tracked via the Priya Life Science Turkey tracker
Phase
Not applicable
Started
2025-10-01
Last updated
2025-09-18

Condition(s) studied

Heel Lance ProceduresPain Management

Investigational drug(s) / intervention(s)

Su Jok Application

Su Jok Application: Description: The newborn's hands will be used for the application. Su Jok therapy will be administered by applying massage and seeds to the corresponding reflection points on the hand prior to the he

Study summary

Objective: To determine the effect of Su Jok therapy on pain levels during the heel lance procedure in newborns. The study will be conducted as a randomized controlled experimental trial with a pretest-posttest control group design. The heel lance procedure will be video recorded, and pain assessment will be performed independently by an experienced neonatal intensive care nurse with 7 years of clinical expertise and a neonatologist, using validated pain assessment scales.

Eligibility

Sex
ALL
Min age
1 Day
Max age
1 Week
Healthy volunteers
Accepted
Inclusion Criteria: * Term newborns (≥37 gestational weeks) * Without neurological disorders * Who have not undergone any painful procedure (e.g., injection, venipuncture) in the previous 24 hours * For whom heel lance for routine screening tests is planned * Whose parents provided written informed consent * Who have not received analgesic or sedative medications Exclusion Criteria: * Clinically unstable infants before or during the procedure (e.g., respiratory distress, cardiac instability) * Infants whose position was changed, intervention was interrupted, or procedure repeated in a way that could affect pain perception * Parental withdrawal of consent during the procedure * Severe restlessness or sudden physiological changes preventing pain assessment * Infants for whom standardized data could not be collected due to protocol violations

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
ataturk University Erzurum Turkey (Türkiye)

More Ataturk University trials in Turkey

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07164820 on ClinicalTrials.gov ↗ ← All trials in Turkey